Page last updated: 2024-12-06

improsan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

improsan: synonyms NSC-102627, alkylating agent 864 & yoshi 864 refer to HCl; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18949
CHEMBL ID96292
CHEBI ID135202
SCHEMBL ID8954
MeSH IDM0041645

Synonyms (37)

Synonym
CHEMBL96292
improsulfan
3,3-iminobis-1-propanol dimethanesulfonate (ester)
improsan
1-propanol, 3,3'-iminodi-, dimethanesulfonate (ester)
improsulfan [inn]
3,3'-iminodi-1-propanol dimethanesulfonate (ester)
improsulfano [inn-spanish]
improsulfanum [inn-latin]
brn 1981708
3,3'-iminobis-1-propanol dimethanesulfonate
3,3'-iminobis(1-propanol) dimethanesulfonate
1-propanol, 3,3-iminobis-, dimethanesulfonate (ester)
nsc102627
3, 3'-dimesyloxydipropylamine hydrochloride
3, 3'-iminodi-1-propanol dimethanesulfonate ester hydrochloride
compound 864 (*hydrochloride*)
3,3'-imidodi-1-propanol, dimethanesulfonate (ester)-
3, 3'-iminodi-1-propanol di(methanesulfonate) hydrochloride
3-(3-methylsulfonyloxypropylamino)propyl methanesulfonate
3-((3-((methylsulfonyl)oxy)propyl)amino)propyl methanesulfonate
864 (*hydrochloride*)
NCI60_000072
CHEBI:135202
13425-98-4
unii-32y1f7n1zd
improsulfanum
improsulfano
32y1f7n1zd ,
SCHEMBL8954
3,3'-iminodi-1-propanol dimethanesulphonate (ester)
improsulfan [who-dd]
improsulfan [mi]
DTXSID6043832
bis(3-mesyloxypropyl)-amine
3-n-boc-amino-3-(3-cbz)piperidine-propionicacidethylester
Q27256199

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The combination treatments with 6-thioguanine and each of six agents, especially with ACNU, showed a distinct therapeutic effect against the early L-1210 leukemia at dosage levels not producing any significant antitumor activity with each agent alone (ip-ip)."( Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
Fujimoto, S; Horikoshi, N; Hoshino, A; Inagaki, J, 1977
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organosulfonic esterAn ester resulting from the formal condensation of the hydroxy group of an alcohol, phenol, heteroarenol, or enol with an organosulfonic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID227701Anticonvulsant activity; NC denotes that compound is not classified2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (81.82)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.01 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (27.27%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (72.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]